Data‐driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Introduction: We sought to assess longitudinal electronic health records (EHRs) using machine learning (ML) methods to computationally derive probable Alzheimer's Disease (AD) and related dementia subphenotypes. Methods: A retrospective analysis of EHR data from a cohort of 7587 patients seen at a large, multi‐specialty urban academic medical center in New York was conducted. Subphenotypes were derived using hierarchical clustering from 792 probable AD patients (cases) who had received at least one diagnosis of AD using their clinical data. The other 6795 patients, labeled as controls, were matched on age and gender with the cases and randomly selected in the ratio of 9:1. Prediction models with multiple ML algorithms were trained on this cohort using 5‐fold cross‐validation. XGBoost was used to rank the variable importance. Results: Four subphenotypes were computationally derived. Subphenotype A (n = 273; 28.2%) had more patients with cardiovascular diseases; subphenotype B (n = 221; 27.9%) had more patients with mental health illnesses, such as depression and anxiety; patients in subphenotype C (n = 183; 23.1%) were overall older (mean (SD) age, 79.5 (5.4) years) and had the most comorbidities including diabetes, cardiovascular diseases, and mental health disorders; and subphenotype D (n = 115; 14.5%) included patients who took anti‐dementia drugs and had sensory problems, such as deafness and hearing impairment. The 0‐year prediction model for AD risk achieved an area under the receiver operating curve (AUC) of 0.764 (SD: 0.02); the 6‐month model, 0.751 (SD: 0.02); the 1‐year model, 0.752 (SD: 0.02); the 2‐year model, 0.749 (SD: 0.03); and the 3‐year model, 0.735 (SD: 0.03), respectively. Based on variable importance, the top‐ranked comorbidities included depression, stroke/transient ischemic attack, hypertension, anxiety, mobility impairments, and atrial fibrillation. The top‐ranked medications included anti‐dementia drugs, antipsychotics, antiepileptics, and antidepressants. Conclusions: Four subphenotypes were computationally derived that correlated with cardiovascular diseases and mental health illnesses. ML algorithms based on patient demographics, diagnosis, and treatment demonstrated promising results in predicting the risk of developing AD at different time points across an individual's lifespan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
Brookmeyer, R., Abdalla, N., Kawas, C. H., & Corrada, M. M. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.10.009 · Cited by 406 · cited 1×
“18,19 Clinical studies also demonstrated that patients with chronic kidney disease are more prone to cognitive impairment and AD.”
BackgroundMixed Dementia—the Most Common Cause of Dementia
KORCZYN, A. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04807.x · Cited by 219
Phenomenology of Depression in Alzheimer’s Disease
Novais, F., & Starkstein, S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-148004 · Cited by 85
Advancing Alzheimer’s research: a review of big data promises
Zhang, R., Simon, G., & Yu, F. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.07.002 · Cited by 77
Cited by
Tang, A. S., Rankin, K. P., Cerono, G., Miramontes, S., Mills, H., Roger, J., Zeng, B., Nelson, C., Soman, K., Woldemariam, S., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00573-8 · Cited by 86
Harnessing EHR data for health research
Tang, A. S., Woldemariam, S. R., Miramontes, S., Norgeot, B., Oskotsky, T. T., & Sirota, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-03074-8 · Cited by 87
“Indeed, some prior association analyses and models for AD pick up the prescription of an anti-dementia drug before an official AD diagnosis 64 .”
Mao, C., Xu, J., Rasmussen, L., Li, Y., Adekkanattu, P., Pacheco, J., Bonakdarpour, B., Vassar, R., Shen, L., Jiang, G., et al. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104442 · Cited by 67
Self-citationCheng, F., Wang, F., Tang, J., Zhou, Y., Fu, Z., Zhang, P., Haines, J. L., Leverenz, J. B., Gan, L., Hu, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101379 · Cited by 63
Self-citationWest, M., Cheng, Y., He, Y., Leng, Y., Magdamo, C., Hyman, B. T., Dickson, J. R., Serrano-Pozo, A., Blacker, D., & Das, S. (2025) · JMIR Aging · doi:10.2196/65178 · Cited by 8
Metadata
- Authors
- Xu, J., Wang, F., Xu, Z., Adekkanattu, P., Brandt, P., Jiang, G., Kiefer, R. C., Luo, Y., Mao, C., Pacheco, J. A., Rasmussen, L. V., Zhang, Y., Isaacson, R., & Pathak, J.
- Venue
- Learning Health Systems
- Publisher
- Wiley
- Published
- 2020-09-10
- Volume
- 4
- Issue
- 4
- Pages
- e10246-e10246
- ISSN
- 2379-6146 (ISSN-L)
- OpenAlex
- W3088033826
- Cited by
- 38
- References
- 5
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Data‐driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records. https://app.cochat.ai/papers/10.1002/lrh2.10246
- The paper
- Xu, J., Wang, F., Xu, Z., Adekkanattu, P., Brandt, P., Jiang, G., Kiefer, R. C., Luo, Y., Mao, C., Pacheco, J. A., Rasmussen, L. V., Zhang, Y., Isaacson, R., & Pathak, J. (2020). Data‐driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records. Learning Health Systems. https://doi.org/10.1002/lrh2.10246
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.